FDA previews safety-focused STeP pathway, finalizes breakthrough device guidance

FDA Revises 1989 Guidance on Drug Master Files

Roche, Novo Nordisk and Merck Weigh in on FDA Draft Guidance on Assessment of Pressor Effects
drapeau_union_europenne-1